Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Revenue Breakdown

Chart: Revenue Breakdown for Zealand Pharma. Values in USD billions. In Q2 2026: Revenue 0.692, Gross Profit 0.69, Operating Income 0.594.

Revenue Flow

Chart: Revenue Flow for Zealand Pharma. Q2 2026, values in USD. Revenue 27%, Gross Profit 27%, Net Income 23%, Operating Income 23%, Cost of Revenue 0%.

Balance Sheet

Chart: Balance Sheet for Zealand Pharma. Values in currency. In Q2 2026: Total Assets 3.043, Total Liabilities 0.271, Total Equity 2.772.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Zealand Pharma. Values in currency. In Q2 2026: Operating Cash Flow 0.063, Free Cash Flow 0.061, Capital Expenditures 0.002.

Q3 2016-Q2 2026

Zealand Pharma (ZEAL.CO) - Compare | Sterling

Revenue Breakdown

Chart: Revenue Breakdown for Zealand Pharma. Values in USD billions. In Q2 2026: Revenue 0.692, Gross Profit 0.69, Operating Income 0.594.

Revenue Flow

Chart: Revenue Flow for Zealand Pharma. Q2 2026, values in USD. Revenue 27%, Gross Profit 27%, Net Income 23%, Operating Income 23%, Cost of Revenue 0%.

Balance Sheet

Chart: Balance Sheet for Zealand Pharma. Values in currency. In Q2 2026: Total Assets 3.043, Total Liabilities 0.271, Total Equity 2.772.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Zealand Pharma. Values in currency. In Q2 2026: Operating Cash Flow 0.063, Free Cash Flow 0.061, Capital Expenditures 0.002.

Q3 2016-Q2 2026